William Blair Initiates Coverage On Climb Bio with Outperform Rating

Climb Bio Inc. Ordinary Shares -6.15%

Climb Bio Inc. Ordinary Shares

CLYM

1.83

-6.15%

William Blair analyst Matt Phipps initiates coverage on Climb Bio (NASDAQ: CLYM) with a Outperform rating.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via